Cassava Sciences, Inc.
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational dia…
Biotechnology
US, Austin [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group
Peers Performance
Similar Stocks · Adjusted CloseA quick analysis that compared Cassava Sciences, Inc. (SAVA) to it's peer group.
Peer Group
MDGL KRYS VIR EXEL AXSM RETA TGTX CVAC AVXL BTAI CGTX BIVI INMB RVPH VKTX MCRB ANVS
Compare Together
Loading...